首页 > 最新文献

Healthcare infection最新文献

英文 中文
Shelf life of sterilized packaged items stored in acute care hospital settings: factors for consideration 在急症护理医院储存的灭菌包装物品的保质期:需要考虑的因素
Pub Date : 2013-09-01 DOI: 10.1071/HI13002
Prabha Lakhan BN, MN, PhD , Joan Faoagali MBChB, MPH, FRCPA , Rosemary Steinhardt BHSc, GradCertMngt, GradDipInfection Control , Dolly Olesen Grad Dip(Clinical Nursing Studies), MHSc(Infection Control)

Introduction

Reusable medical devices are sterilized and stored before their use in hospital settings. The length of time the sterilized item can be stored (shelf life) to maintain sterility has been discussed in the literature over the last four decades, with a shift to an event rather than time-related determination of shelf life. This paper reviews the evidence and provides a summary of some key issues for consideration when adopting event-related or time-based shelf life recommendations for packaged sterile items in Australian hospitals.

Discussion

Australian and international standards provide guidelines for procedures to be used for sterilization of reusable medical devices and storage conditions following sterilization. Reusable medical devices are sterilized by commercial manufacturers or sterilizing departments located in hospitals. Commercial manufacturers allocate expiry dates on sterilized items which should be respected, unless sterility is compromised by an event. The shelf life of items sterilized in hospital is debated, with growing support for event- rather than time-related sterility. Many factors determine whether event- or time-related shelf life should be followed. Well designed experimental studies into shelf life of sterilized items are lacking, with some small studies indicating that items can remain sterile for 12 to 24 months. Factors for consideration by hospitals are outlined and an algorithm to assist in implementation of event-related or time-based shelf life for reprocessed reusable medical devices is provided.

Conclusion

The method of determining shelf life in hospitals is dependent on adequacy of processes for sterilization, monitoring of sterility over time and storage conditions.

可重复使用的医疗器械在医院使用前要进行消毒和储存。在过去的四十年中,文献中讨论了灭菌物品可以储存的时间长度(保质期)以保持无菌,并转向事件而不是与时间相关的保质期决定。本文回顾了证据,并提供了一些关键问题的总结,当采用事件相关或基于时间的保质期建议包装无菌项目在澳大利亚医院考虑。讨论澳大利亚和国际标准为可重复使用医疗器械的灭菌程序和灭菌后的储存条件提供了指南。可重复使用的医疗器械由商业制造商或医院的消毒部门消毒。除非无菌性受到事件的影响,否则商业制造商应遵守灭菌物品的有效期。医院消毒物品的保质期一直备受争议,越来越多的人支持与事件有关而不是与时间有关的消毒。许多因素决定了是否应该遵循与事件或时间相关的保质期。设计良好的灭菌物品保质期实验研究缺乏,一些小型研究表明,物品可以保持无菌12至24个月。概述了医院应考虑的因素,并提供了一种算法,以协助实施与事件相关或基于时间的可重复使用医疗设备的保质期。结论确定医院药品货架期的方法取决于灭菌过程的充分性、无菌时间的监测和储存条件。
{"title":"Shelf life of sterilized packaged items stored in acute care hospital settings: factors for consideration","authors":"Prabha Lakhan BN, MN, PhD ,&nbsp;Joan Faoagali MBChB, MPH, FRCPA ,&nbsp;Rosemary Steinhardt BHSc, GradCertMngt, GradDipInfection Control ,&nbsp;Dolly Olesen Grad Dip(Clinical Nursing Studies), MHSc(Infection Control)","doi":"10.1071/HI13002","DOIUrl":"10.1071/HI13002","url":null,"abstract":"<div><h3>Introduction</h3><p>Reusable medical devices are sterilized and stored before their use in hospital settings. The length of time the sterilized item can be stored (shelf life) to maintain sterility has been discussed in the literature over the last four decades, with a shift to an event rather than time-related determination of shelf life. This paper reviews the evidence and provides a summary of some key issues for consideration when adopting event-related or time-based shelf life recommendations for packaged sterile items in Australian hospitals.</p></div><div><h3>Discussion</h3><p>Australian and international standards provide guidelines for procedures to be used for sterilization of reusable medical devices and storage conditions following sterilization. Reusable medical devices are sterilized by commercial manufacturers or sterilizing departments located in hospitals. Commercial manufacturers allocate expiry dates on sterilized items which should be respected, unless sterility is compromised by an event. The shelf life of items sterilized in hospital is debated, with growing support for event- rather than time-related sterility. Many factors determine whether event- or time-related shelf life should be followed. Well designed experimental studies into shelf life of sterilized items are lacking, with some small studies indicating that items can remain sterile for 12 to 24 months. Factors for consideration by hospitals are outlined and an algorithm to assist in implementation of event-related or time-based shelf life for reprocessed reusable medical devices is provided.</p></div><div><h3>Conclusion</h3><p>The method of determining shelf life in hospitals is dependent on adequacy of processes for sterilization, monitoring of sterility over time and storage conditions.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 3","pages":"Pages 121-129"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI13002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59235585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Healthcare waste disposal: an analysis of the effect of education on improving waste disposal 医疗废物处理:教育对改善废物处理效果的分析
Pub Date : 2013-09-01 DOI: 10.1071/HI12050
Karen Hames RN, GradCert(Crit Care), GradDip(Environ)

Background

Inappropriate disposal of clinical waste has a considerable environmental and financial impact. Other studies have shown substantial opportunities for improvement in healthcare waste disposal. This study aims to show these opportunities through a clinical waste audit and to gain a greater understanding into approaches required for successful waste disposal behaviour change.

Methods

A clinical waste audit was conducted in an eight-bed intensive care unit in Melbourne. A baseline audit was followed by a questionnaire and education (in-services and signage). A follow up audit was performed to analyse the effect of education.

Results

Results of the initial clinical waste audit showed 41% clinical waste, 44% general waste and 14% sharps waste. Post-education, clinical waste was slightly greater than general waste and sharps waste had markedly decreased to 3.5%, however, study limitations were present. The marked decline in sharps waste appears to mainly be due to the clarification of a misnomer regarding disposal of glass. Questionnaires showed a lack of knowledge but a desire to learn, and a preference for learning through signage and in-services.

Conclusion

The study shows that more than one in-service and increased signage is needed for successful behaviour change. This supports findings that active staff involvement is essential to achieve sustainable waste management.

背景:适当处置医疗废物会对环境和财政产生重大影响。其他研究表明,在医疗保健废物处理方面有大量改进机会。这项研究旨在透过医疗废物审核,展示这些机会,并进一步了解成功改变废物处置行为所需的方法。方法对墨尔本一家8床重症监护病房进行医疗废物审计。基线审计之后是问卷调查和教育(在职和标牌)。进行了跟踪审计,以分析教育的效果。结果初步医疗废物审核结果显示,医疗废物占41%,一般废物占44%,尖锐废物占14%。教育结束后,医疗废物略高于一般废物,锐器废物显著下降至3.5%,然而,研究存在局限性。尖锐废料的显著减少似乎主要是由于澄清了关于处置玻璃的用词不当。调查问卷显示,他们缺乏知识,但有学习的愿望,并倾向于通过标牌和在职学习。结论:研究表明,要想成功地改变行为,不止一个正在使用和增加的标牌是必要的。这支持了工作人员积极参与对实现可持续废物管理至关重要的结论。
{"title":"Healthcare waste disposal: an analysis of the effect of education on improving waste disposal","authors":"Karen Hames RN, GradCert(Crit Care), GradDip(Environ)","doi":"10.1071/HI12050","DOIUrl":"10.1071/HI12050","url":null,"abstract":"<div><h3>Background</h3><p>Inappropriate disposal of clinical waste has a considerable environmental and financial impact. Other studies have shown substantial opportunities for improvement in healthcare waste disposal. This study aims to show these opportunities through a clinical waste audit and to gain a greater understanding into approaches required for successful waste disposal behaviour change.</p></div><div><h3>Methods</h3><p>A clinical waste audit was conducted in an eight-bed intensive care unit in Melbourne. A baseline audit was followed by a questionnaire and education (in-services and signage). A follow up audit was performed to analyse the effect of education.</p></div><div><h3>Results</h3><p>Results of the initial clinical waste audit showed 41% clinical waste, 44% general waste and 14% sharps waste. Post-education, clinical waste was slightly greater than general waste and sharps waste had markedly decreased to 3.5%, however, study limitations were present. The marked decline in sharps waste appears to mainly be due to the clarification of a misnomer regarding disposal of glass. Questionnaires showed a lack of knowledge but a desire to learn, and a preference for learning through signage and in-services.</p></div><div><h3>Conclusion</h3><p>The study shows that more than one in-service and increased signage is needed for successful behaviour change. This supports findings that active staff involvement is essential to achieve sustainable waste management.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 3","pages":"Pages 110-114"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI12050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59234907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
The relationship between patient characteristics and the development of a multi-resistant healthcare-associated infection in a private South Australian hospital 病人的特点和发展之间的关系多耐药医疗保健相关感染在私立南澳大利亚医院
Pub Date : 2013-09-01 DOI: 10.1071/HI13010
L.S. Jarratt MPH , E.R. Miller PhD

Background

The prevention of healthcare-associated infections (HAI) and the rise of multi-resistant organisms are significant public health issues. Infections caused by multi-resistant organisms (MRO) can have similar clinical manifestations to infections caused by non-multi-resistant organisms (non-MROHAI) but antibiotic treatment options are more limited, which can result in treatment failure. This study aimed to reduce the incidence of MRO HAI in a specific South Australian hospital setting by identifying factors that are associated with MRO transmission.

Methods

Using a case-control design, we analysed data from 1017 adult patients who developed an HAI in the 9-year period from 2003 to 2011 in a private South Australian hospital. We compared risk factors in patients who developed MRO HAI (cases) with risk factors in patients who developed non-MRO HAI (controls). Data were collected from the hospital's patient management database and individual medical records, and analysed using univariate and multivariate techniques.

Results

Independent predictors for the development of MRO HAI were the presence of an indwelling urinary catheter and renal disease. The development of a secondary infection was significantly more likely in MRO relative to non-MRO HAI, as was secondary bloodstream infection following a primary urinary tract infection.

Conclusion

All effective interventions for reducing MRO, specifically in UTI, should be implemented where feasible. Increased healthcare worker education on aseptic non-touch technique, and safe insertion and management of an IDC, particularly important in patients with underlying renal disease, could assist in decreasing the risk of MRO HAI in this setting.

卫生保健相关感染(HAI)的预防和多重耐药菌的增加是重大的公共卫生问题。多重耐药菌(MRO)引起的感染可能具有与非多重耐药菌(non-MROHAI)引起的感染相似的临床表现,但抗生素治疗选择更为有限,这可能导致治疗失败。本研究旨在通过确定与MRO传播相关的因素,降低南澳大利亚特定医院MRO HAI的发病率。方法采用病例对照设计,对2003 - 2011年9年间在南澳大利亚一家私立医院发生HAI的1017例成年患者的资料进行分析。我们比较了MRO型HAI患者(病例)和非MRO型HAI患者(对照组)的危险因素。数据从医院的患者管理数据库和个人医疗记录中收集,并使用单变量和多变量技术进行分析。结果MRO HAI发展的独立预测因素是留置导尿管和肾脏疾病的存在。与非MRO HAI相比,MRO患者继发感染的可能性更大,原发性尿路感染后继发血流感染也是如此。结论所有降低MRO的有效干预措施,特别是尿路感染,应在可行的情况下实施。加强医护人员对无菌非接触技术的教育,安全插入和管理IDC,特别是对有潜在肾脏疾病的患者,可以帮助降低MRO HAI的风险。
{"title":"The relationship between patient characteristics and the development of a multi-resistant healthcare-associated infection in a private South Australian hospital","authors":"L.S. Jarratt MPH ,&nbsp;E.R. Miller PhD","doi":"10.1071/HI13010","DOIUrl":"10.1071/HI13010","url":null,"abstract":"<div><h3>Background</h3><p>The prevention of healthcare-associated infections (HAI) and the rise of multi-resistant organisms are significant public health issues. Infections caused by multi-resistant organisms (MRO) can have similar clinical manifestations to infections caused by non-multi-resistant organisms (non-MROHAI) but antibiotic treatment options are more limited, which can result in treatment failure. This study aimed to reduce the incidence of MRO HAI in a specific South Australian hospital setting by identifying factors that are associated with MRO transmission.</p></div><div><h3>Methods</h3><p>Using a case-control design, we analysed data from 1017 adult patients who developed an HAI in the 9-year period from 2003 to 2011 in a private South Australian hospital. We compared risk factors in patients who developed MRO HAI (cases) with risk factors in patients who developed non-MRO HAI (controls). Data were collected from the hospital's patient management database and individual medical records, and analysed using univariate and multivariate techniques.</p></div><div><h3>Results</h3><p>Independent predictors for the development of MRO HAI were the presence of an indwelling urinary catheter and renal disease. The development of a secondary infection was significantly more likely in MRO relative to non-MRO HAI, as was secondary bloodstream infection following a primary urinary tract infection.</p></div><div><h3>Conclusion</h3><p>All effective interventions for reducing MRO, specifically in UTI, should be implemented where feasible. Increased healthcare worker education on aseptic non-touch technique, and safe insertion and management of an IDC, particularly important in patients with underlying renal disease, could assist in decreasing the risk of MRO HAI in this setting.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 3","pages":"Pages 94-101"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI13010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59235428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Vancomycin-resistant enterococci surveillance of intensive care patients: incidence and outcome of colonisation 重症监护患者耐万古霉素肠球菌监测:定植的发生率和结果
Pub Date : 2013-09-01 DOI: 10.1071/HI11025
Elena Iolovska GradCert(Public Administration), BSc, BCom , Heather Bullard BAppSci (Nursing) , Wendy Beckingham BHSc(Nursing), MClinicalNurs , Peter Collignon AM, FRACP, FRCPA , Imogen Mitchell FRCP , Bronwyn Avard BMed, MLMEd, FCICM

Background

Vancomycin-resistant enterococci (VRE) colonisation serves as a reservoir and increases the risk of developing an infection with VRE. Treatment difficulties and infection control measures associated with vancomycin-resistant enterococci present significant costs to health care facilities. To determine the incidence of VRE colonisation in ICU, data collected included hospital and ICU admission, discharge dates, positive and negative VRE swabs for each hospital or ICU admission.

Methods

This study was performed to identify the number of VRE colonisations occurring in the Intensive Care Unit (ICU) and the outcome of these colonised patients. The clinical records of 99 VRE patients identified as having been to ICU during 2009 and 2010 were reviewed.

Results

These patients had a total of 111 ICUadmissions. Of these, 30 were classified as definite or probable ICUacquired VRE colonisations. This equated to 30.1 acquisitions per 10 000 occupied bed days. Thirty-eight patients acquired their VRE from clinical areas other than ICU. In 24 other patients the place of VRE could not be ascertained. In another 19 patients VRE was present when they were admitted from the community but 15 of these (79%) had been hospitalised within the last year. Of the 30 ICU-colonised patients, none developed infections. However, three patients initially colonised in another clinical area developed an infection with VRE while in ICU.

Conclusion

Our study supports the findings of others that most people at risk of VRE colonisation or infection are severely unwell. The high level of colonisation occurring in other clinical areas added to the healthcare expenses in ICU. The increased costs associated with VRE and our findings indicate a greater need to better control VRE transmission not only in the ICU, but in all health care settings.

背景万古霉素耐药肠球菌(VRE)定植是一个储存库,增加了VRE感染的风险。与万古霉素耐药肠球菌相关的治疗困难和感染控制措施给卫生保健机构带来了巨大的成本。为了确定ICU中VRE定植的发生率,收集的数据包括医院和ICU入院情况、出院日期、每家医院或ICU入院的VRE拭子阳性和阴性。方法本研究旨在确定发生在重症监护病房(ICU)的VRE定植数量和这些定植患者的结果。回顾2009 ~ 2010年间99例入ICU的VRE患者的临床记录。结果本组患者共住院111例。其中,30例被归类为明确或可能的未获得性VRE殖民。这相当于每1万个床位日有30.1次收购。38例患者的VRE来自ICU以外的临床区域。另有24例患者VRE位置无法确定。另外19例患者从社区入院时存在VRE,但其中15例(79%)在去年住院。在30例icu患者中,没有一例发生感染。然而,最初在另一个临床区域定植的3例患者在ICU期间发生VRE感染。结论我们的研究支持了其他研究结果,即大多数有VRE定植或感染风险的人都严重不适。在其他临床领域发生的高水平定植增加了ICU的医疗费用。与VRE相关的费用增加以及我们的研究结果表明,不仅在ICU,而且在所有卫生保健环境中,更需要更好地控制VRE传播。
{"title":"Vancomycin-resistant enterococci surveillance of intensive care patients: incidence and outcome of colonisation","authors":"Elena Iolovska GradCert(Public Administration), BSc, BCom ,&nbsp;Heather Bullard BAppSci (Nursing) ,&nbsp;Wendy Beckingham BHSc(Nursing), MClinicalNurs ,&nbsp;Peter Collignon AM, FRACP, FRCPA ,&nbsp;Imogen Mitchell FRCP ,&nbsp;Bronwyn Avard BMed, MLMEd, FCICM","doi":"10.1071/HI11025","DOIUrl":"10.1071/HI11025","url":null,"abstract":"<div><h3>Background</h3><p>Vancomycin-resistant enterococci (VRE) colonisation serves as a reservoir and increases the risk of developing an infection with VRE. Treatment difficulties and infection control measures associated with vancomycin-resistant enterococci present significant costs to health care facilities. To determine the incidence of VRE colonisation in ICU, data collected included hospital and ICU admission, discharge dates, positive and negative VRE swabs for each hospital or ICU admission.</p></div><div><h3>Methods</h3><p>This study was performed to identify the number of VRE colonisations occurring in the Intensive Care Unit (ICU) and the outcome of these colonised patients. The clinical records of 99 VRE patients identified as having been to ICU during 2009 and 2010 were reviewed.</p></div><div><h3>Results</h3><p>These patients had a total of 111 ICUadmissions. Of these, 30 were classified as definite or probable ICUacquired VRE colonisations. This equated to 30.1 acquisitions per 10 000 occupied bed days. Thirty-eight patients acquired their VRE from clinical areas other than ICU. In 24 other patients the place of VRE could not be ascertained. In another 19 patients VRE was present when they were admitted from the community but 15 of these (79%) had been hospitalised within the last year. Of the 30 ICU-colonised patients, none developed infections. However, three patients initially colonised in another clinical area developed an infection with VRE while in ICU.</p></div><div><h3>Conclusion</h3><p>Our study supports the findings of others that most people at risk of VRE colonisation or infection are severely unwell. The high level of colonisation occurring in other clinical areas added to the healthcare expenses in ICU. The increased costs associated with VRE and our findings indicate a greater need to better control VRE transmission not only in the ICU, but in all health care settings.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 3","pages":"Pages 115-120"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI11025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59233149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Long-term survival outcome following Staphylococcus aureus bacteraemia 金黄色葡萄球菌血症后的长期生存结局
Pub Date : 2013-09-01 DOI: 10.1071/HI12062
Chong W. Ong MBBS(Hons), FRACP, FRCPA , Jan L. Roberts RN, BHSc(Nursing), CICP , Peter J. Collignon MBBS(Hons), BSc(Med), FASM, FRACP, FRCPA

Aims

To describe long-term survival (beyond 200 days) following Staphylococcus aureus bacteraemia (SAB) and to determine if certain patient subgroups had poorer long-term survival outcomes.

Methods

A single-centre, retrospective, cohort study of all SAB cases at The Canberra Hospital, a tertiary referral centre, from January 1998 to December 2007 was performed. Clinical and demographic data were obtained from a pre-existing prospectively collected database. Patients were followed-up for a minimum of 9 months. Subsets within the cohort were analysed for differences in long-term survival. The main outcome measure was death from any cause.

Results

During the 3889-day study observation period, 439 patients had SAB and were followed for a total of 546 360 person-days. The overall median survival was 3169 days. The mortality rates were 9.6%, 17%, 24%, 29% and 32% at 7, 30, 90, 180 and 365 days respectively. Atotal of 188 (43%) patients died. Of the 188 deaths, 22%, 40%, 55%, 67% and 75% occurred within the first 7, 30, 90, 180 and 365 days respectively after their SAB episode. Initial analysis showed poorer long-term survival in those patients with older age, MRSA, with an unknown focus of infection, and who were not admitted under the Infectious Diseases team. However, on multivariate analysis, the only independent risk factors for poorer survival were older age, unknown focus of infection and not being admitted under the Infectious Diseases team. MRSA, sex, surgical vs non-surgical admitting team and an association with an intravascular device were not associated with poorer long-term survival.

Conclusions

High rates of death continue for many months after patients have an episode of SAB. Short-term follow-up studies (30 days or less) may miss large numbers of SAB-associated deaths. If accurate data on SAB associated mortality is needed, then follow-up of these patients will be needed for at least 90 days, ideally performed prospectively with a matched control group consisting of hospitalised patients without SAB.

目的描述金黄色葡萄球菌血症(SAB)后的长期生存(超过200天),并确定某些患者亚组是否有较差的长期生存结果。方法对1998年1月至2007年12月三级转诊中心堪培拉医院的所有SAB病例进行单中心、回顾性、队列研究。临床和人口统计数据从预先存在的前瞻性收集的数据库中获得。患者随访至少9个月。对队列中的亚组进行长期生存差异分析。主要结局指标是任何原因导致的死亡。结果在3889天的研究观察期内,439例患者发生SAB,共随访546 360人次天。总中位生存期为3169天。第7、30、90、180和365天的死亡率分别为9.6%、17%、24%、29%和32%。共有188例(43%)患者死亡。在188例死亡病例中,分别有22%、40%、55%、67%和75%发生在SAB发作后的前7天、30天、90天、180天和365天。初步分析显示,年龄较大、MRSA感染灶不明、不在传染病组住院的患者长期生存率较差。然而,在多变量分析中,生存率较低的唯一独立风险因素是年龄较大,感染焦点未知以及未在传染病小组下入院。MRSA、性别、手术与非手术入院团队以及与血管内装置的关联与较差的长期生存率无关。结论SAB发作后患者的高死亡率持续数月。短期随访研究(30天或更短)可能遗漏大量与sabb相关的死亡病例。如果需要SAB相关死亡率的准确数据,则需要对这些患者进行至少90天的随访,理想情况下,与没有SAB的住院患者组成的匹配对照组进行前瞻性随访。
{"title":"Long-term survival outcome following Staphylococcus aureus bacteraemia","authors":"Chong W. Ong MBBS(Hons), FRACP, FRCPA ,&nbsp;Jan L. Roberts RN, BHSc(Nursing), CICP ,&nbsp;Peter J. Collignon MBBS(Hons), BSc(Med), FASM, FRACP, FRCPA","doi":"10.1071/HI12062","DOIUrl":"10.1071/HI12062","url":null,"abstract":"<div><h3>Aims</h3><p>To describe long-term survival (beyond 200 days) following <em>Staphylococcus aureus</em> bacteraemia (SAB) and to determine if certain patient subgroups had poorer long-term survival outcomes.</p></div><div><h3>Methods</h3><p>A single-centre, retrospective, cohort study of all SAB cases at The Canberra Hospital, a tertiary referral centre, from January 1998 to December 2007 was performed. Clinical and demographic data were obtained from a pre-existing prospectively collected database. Patients were followed-up for a minimum of 9 months. Subsets within the cohort were analysed for differences in long-term survival. The main outcome measure was death from any cause.</p></div><div><h3>Results</h3><p>During the 3889-day study observation period, 439 patients had SAB and were followed for a total of 546 360 person-days. The overall median survival was 3169 days. The mortality rates were 9.6%, 17%, 24%, 29% and 32% at 7, 30, 90, 180 and 365 days respectively. Atotal of 188 (43%) patients died. Of the 188 deaths, 22%, 40%, 55%, 67% and 75% occurred within the first 7, 30, 90, 180 and 365 days respectively after their SAB episode. Initial analysis showed poorer long-term survival in those patients with older age, MRSA, with an unknown focus of infection, and who were not admitted under the Infectious Diseases team. However, on multivariate analysis, the only independent risk factors for poorer survival were older age, unknown focus of infection and not being admitted under the Infectious Diseases team. MRSA, sex, surgical vs non-surgical admitting team and an association with an intravascular device were not associated with poorer long-term survival.</p></div><div><h3>Conclusions</h3><p>High rates of death continue for many months after patients have an episode of SAB. Short-term follow-up studies (30 days or less) may miss large numbers of SAB-associated deaths. If accurate data on SAB associated mortality is needed, then follow-up of these patients will be needed for at least 90 days, ideally performed prospectively with a matched control group consisting of hospitalised patients without SAB.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 3","pages":"Pages 102-109"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI12062","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59235526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
The provision of infection prevention and control services in the public health sector in New Zealand 在新西兰公共卫生部门提供感染预防和控制服务
Pub Date : 2013-09-01 DOI: 10.1071/HI13017
Sally Roberts MBChB, FRACP, FRCPA

Infection prevention and control services are well established within publically funded hospitals within New Zealand. In 2007, the Ministry of Health Quality Improvement Committee developed a set of National Quality Improvement Programs including an Infection Prevention and Control project. This project, the implementation of a national hand hygiene program, provision of guidance to reduce central line associated bacteraemia and recommendations for a national surgical site infection surveillance program, was the first nationally coordinated infection prevention and control program. More recently the Health Quality and Safety Commission has been established and the responsibility of the program delivery shifted to the Commission. District Health Boards have agreed to participate in the programs and the recently introduced Quality and Safety Markers will track the progress of these programs. Ongoing committed to increasing the workforce capacity and capability is required to ensure the successful delivery of these programs.

新西兰公立医院的感染预防和控制服务都很完善。2007年,卫生部质量改进委员会制定了一套国家质量改进方案,其中包括一个感染预防和控制项目。该项目实施了国家手部卫生规划,为减少中央静脉相关菌血症提供指导,并为国家手术部位感染监测规划提供建议,是第一个全国协调的感染预防和控制规划。最近成立了卫生质量和安全委员会,并将方案实施的责任移交给该委员会。地区卫生局已同意参与这些方案,最近引进的质量和安全标志将跟踪这些方案的进展。为了确保这些项目的成功实施,需要持续致力于提高劳动力能力和能力。
{"title":"The provision of infection prevention and control services in the public health sector in New Zealand","authors":"Sally Roberts MBChB, FRACP, FRCPA","doi":"10.1071/HI13017","DOIUrl":"10.1071/HI13017","url":null,"abstract":"<div><p>Infection prevention and control services are well established within publically funded hospitals within New Zealand. In 2007, the Ministry of Health Quality Improvement Committee developed a set of National Quality Improvement Programs including an Infection Prevention and Control project. This project, the implementation of a national hand hygiene program, provision of guidance to reduce central line associated bacteraemia and recommendations for a national surgical site infection surveillance program, was the first nationally coordinated infection prevention and control program. More recently the Health Quality and Safety Commission has been established and the responsibility of the program delivery shifted to the Commission. District Health Boards have agreed to participate in the programs and the recently introduced Quality and Safety Markers will track the progress of these programs. Ongoing committed to increasing the workforce capacity and capability is required to ensure the successful delivery of these programs.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 3","pages":"Pages 91-93"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI13017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59236160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hand hygiene compliance: the elephant in the room 遵守手部卫生:房间里的大象
Pub Date : 2013-06-01 DOI: 10.1071/HI12056
Stella Stevens PhD , Lynn Hemmings PhD , Craig White MBBS, MBus , Anthony Lawler MBBS, FACEM

Introduction

Hand hygiene compliance rates for medical staff are consistently lower than those for nurses. Strong leadership to improve compliance has been repeatedly called for, but studies exploring medical staff leadership influence are limited. The qualitative study reported here aimed to explore the perceptions that medical staff have of their clinical leaders and the extent to which they influence hand hygiene practice in their clinical units, and to compare this with unit specific compliance data.

Method

Thirty junior doctors from a major tertiary hospital were interviewed or surveyed to uncover their perceptions of clinical leadership and its influence on hand hygiene behaviours. Compliance data for their clinical areas for the corresponding period was obtained and compared with their views on the influence of leadership on hand hygiene behaviour.

Findings

Consultants, rather than infection control nurses, were seen to have the most influence over medical hand hygiene practices. The unit that scored the best on compliance was also the one where the consultant was perceived to have the most influence.

Conclusion

Junior medical staff know that hand hygiene is important but the extent to which they comply with it depends on the influence of the consultant. Infection control staff need to engage consultants in order to improve medical compliance rates, rather than directing their efforts to medical staff in general.

医务人员的手卫生依从率始终低于护士。强有力的领导提高依从性的呼声一再被呼吁,但探索医务人员领导影响的研究有限。本文报道的定性研究旨在探讨医务人员对临床领导的看法,以及他们对临床单位手部卫生实践的影响程度,并将其与单位特定依从性数据进行比较。方法对某大型三级医院的30名初级医生进行访谈或调查,了解他们对临床领导的认知及其对手卫生行为的影响。获得了他们相应时期临床领域的依从性数据,并与他们对领导对手卫生行为影响的看法进行了比较。研究结果显示,在医疗手部卫生习惯方面,咨询师而非感染控制护士的影响力最大。在遵从性方面得分最高的单位,也是顾问被认为最有影响力的单位。结论初级医务人员知道手卫生的重要性,但其遵守程度取决于咨询师的影响。感染控制工作人员需要聘请顾问,以提高医疗依从率,而不是把工作重点放在一般医务人员身上。
{"title":"Hand hygiene compliance: the elephant in the room","authors":"Stella Stevens PhD ,&nbsp;Lynn Hemmings PhD ,&nbsp;Craig White MBBS, MBus ,&nbsp;Anthony Lawler MBBS, FACEM","doi":"10.1071/HI12056","DOIUrl":"10.1071/HI12056","url":null,"abstract":"<div><h3>Introduction</h3><p>Hand hygiene compliance rates for medical staff are consistently lower than those for nurses. Strong leadership to improve compliance has been repeatedly called for, but studies exploring medical staff leadership influence are limited. The qualitative study reported here aimed to explore the perceptions that medical staff have of their clinical leaders and the extent to which they influence hand hygiene practice in their clinical units, and to compare this with unit specific compliance data.</p></div><div><h3>Method</h3><p>Thirty junior doctors from a major tertiary hospital were interviewed or surveyed to uncover their perceptions of clinical leadership and its influence on hand hygiene behaviours. Compliance data for their clinical areas for the corresponding period was obtained and compared with their views on the influence of leadership on hand hygiene behaviour.</p></div><div><h3>Findings</h3><p>Consultants, rather than infection control nurses, were seen to have the most influence over medical hand hygiene practices. The unit that scored the best on compliance was also the one where the consultant was perceived to have the most influence.</p></div><div><h3>Conclusion</h3><p>Junior medical staff know that hand hygiene is important but the extent to which they comply with it depends on the influence of the consultant. Infection control staff need to engage consultants in order to improve medical compliance rates, rather than directing their efforts to medical staff in general.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 2","pages":"Pages 86-89"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI12056","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59235469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Gentamicin and norfloxacin prophylaxis for transrectal ultrasound-guided prostate biopsy 庆大霉素和诺氟沙星在经直肠超声引导前列腺活检中的预防作用
Pub Date : 2013-06-01 DOI: 10.1071/HI12043
Cameron J. Jeremiah MBBS, FRACP , Denis W. Spelman MBBS, FRACP, FRCPA , Peter L. Royce MBBS, FRACS(urol), FACS , Allen C. Cheng MBBS, FRACP, PhD

Background

Transrectal ultrasound guided prostate biopsy (TRUSPB) is the mainstay of diagnosis for prostate cancer. Clinical trials have established that antibiotic prophylaxis is effective in reducing infective complications, but breakthrough bacteraemia has been described with multiresistant organisms. We reviewed the rate of bacteraemia and re-admission in patients undergoing TRUSPB.

Methods

The Alfred Hospital is a tertiary referral hospital in Melbourne, Australia. The routine antibiotic prophylactic regimen is gentamicin and norfloxacin. Patients undergoing TRUSPB at the Alfred Hospital were linked to databases of blood and urine cultures, and to admissions with infective complications within 14 days.

Results

Between June 2007 and July 2010, 459 patients underwent TRUSPB at the Alfred Hospital. No patient (95% CI: 0, 0.8%) had a positive blood culture, and one patient had a positive urine culture (95% CI: 0.04, 1.2%) within 14 days of the procedure. There were two readmissions: a 66 year old man with systemic culture-negative sepsis, and a 54 year old man with a urinary tract infection. In 50 randomly selected patients, all patients received norfloxacin but only 80% of patients received gentamicin. Between 2007 and 2010, 6.0% of isolates were non-susceptible to norfloxacin, 5.8% were non-susceptible to gentamicin and 3.2% were non-susceptible to both gentamicin and norfloxacin.

Conclusions

Recent reports of breakthrough bacteraemia suggest that effectiveness of single agent fluoroquinolone or gentamicin prophylaxis may be compromised by increasing rates of resistance. Combination prophylaxis with gentamicin and norfloxacin is associated with a low rate of infective complications.

背景:经直肠超声引导前列腺活检(TRUSPB)是诊断前列腺癌的主要方法。临床试验已经证实,抗生素预防在减少感染并发症方面是有效的,但突破性菌血症已被描述为多耐药菌。我们回顾了TRUSPB患者的菌血症和再入院率。方法阿尔弗雷德医院是澳大利亚墨尔本的一家三级转诊医院。常规的抗生素预防方案是庆大霉素和诺氟沙星。在阿尔弗雷德医院接受TRUSPB的患者与血液和尿液培养数据库以及14天内感染并发症的住院患者相关联。结果2007年6月至2010年7月,459例患者在阿尔弗雷德医院接受了TRUSPB。手术后14天内,没有患者(95% CI: 0,0.8%)血培养呈阳性,1例患者尿培养呈阳性(95% CI: 0.04, 1.2%)。有两例再次入院:一名66岁的男性患有全身性培养阴性败血症,一名54岁的男性患有尿路感染。在随机选择的50例患者中,所有患者均接受诺氟沙星治疗,但只有80%的患者接受庆大霉素治疗。2007 - 2010年,6.0%的分离株对诺氟沙星不敏感,5.8%的分离株对庆大霉素不敏感,3.2%的分离株对庆大霉素和诺氟沙星均不敏感。结论最近关于突破性菌血症的报道表明,单药氟喹诺酮或庆大霉素预防的有效性可能会因耐药率的增加而受到损害。庆大霉素和诺氟沙星联合预防可降低感染并发症的发生率。
{"title":"Gentamicin and norfloxacin prophylaxis for transrectal ultrasound-guided prostate biopsy","authors":"Cameron J. Jeremiah MBBS, FRACP ,&nbsp;Denis W. Spelman MBBS, FRACP, FRCPA ,&nbsp;Peter L. Royce MBBS, FRACS(urol), FACS ,&nbsp;Allen C. Cheng MBBS, FRACP, PhD","doi":"10.1071/HI12043","DOIUrl":"10.1071/HI12043","url":null,"abstract":"<div><h3>Background</h3><p>Transrectal ultrasound guided prostate biopsy (TRUSPB) is the mainstay of diagnosis for prostate cancer. Clinical trials have established that antibiotic prophylaxis is effective in reducing infective complications, but breakthrough bacteraemia has been described with multiresistant organisms. We reviewed the rate of bacteraemia and re-admission in patients undergoing TRUSPB.</p></div><div><h3>Methods</h3><p>The Alfred Hospital is a tertiary referral hospital in Melbourne, Australia. The routine antibiotic prophylactic regimen is gentamicin and norfloxacin. Patients undergoing TRUSPB at the Alfred Hospital were linked to databases of blood and urine cultures, and to admissions with infective complications within 14 days.</p></div><div><h3>Results</h3><p>Between June 2007 and July 2010, 459 patients underwent TRUSPB at the Alfred Hospital. No patient (95% CI: 0, 0.8%) had a positive blood culture, and one patient had a positive urine culture (95% CI: 0.04, 1.2%) within 14 days of the procedure. There were two readmissions: a 66 year old man with systemic culture-negative sepsis, and a 54 year old man with a urinary tract infection. In 50 randomly selected patients, all patients received norfloxacin but only 80% of patients received gentamicin. Between 2007 and 2010, 6.0% of isolates were non-susceptible to norfloxacin, 5.8% were non-susceptible to gentamicin and 3.2% were non-susceptible to both gentamicin and norfloxacin.</p></div><div><h3>Conclusions</h3><p>Recent reports of breakthrough bacteraemia suggest that effectiveness of single agent fluoroquinolone or gentamicin prophylaxis may be compromised by increasing rates of resistance. Combination prophylaxis with gentamicin and norfloxacin is associated with a low rate of infective complications.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 2","pages":"Pages 67-71"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI12043","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59235022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A study of three methods for assessment of hospital environmental cleaning 医院环境清洁评价的三种方法研究
Pub Date : 2013-06-01 DOI: 10.1071/HI13001
Philip W. Smith MD , Harlan Sayles MS , Angela Hewlett MD, MS , R. Jennifer Cavalieri BSN, RN , Shawn G. Gibbs PhD , Mark E. Rupp MD

Background

The environment is increasingly appreciated as a factor in healthcare associated infections. Several methods for measuring environmental contamination are available. Our goal was to compare quantitative microbiology to adenosine triphosphate (ATP) detection on a sample of hospital surfaces both pre- and post-cleaning, and to assess fluorescent marker results in the same rooms.

Methods

In a sample of 10 rooms, ATP readings by relative light units (RLU) and quantitative determination of colony forming units (CFU) were measured pre- and post-cleaning on 10 high-touch hospital environmental surfaces. Removal of fluorescent markers (FM) was evaluated post-cleaning in the same rooms. Methods were compared using correlational analyses.

Results

The ATP readings were usually higher than CFU readings compared with their respective norms for cleanliness. The direction of change in cleanliness assessment (usually down after cleaning) was consistent between the RLU and CFU methods. In addition, CFU and RLU values correlated pre-cleaning, but not postcleaning. Areceiver operating characteristic (ROC) curve suggested a ‘clean’ cutoff of 8 RLU/cm2 for the ATP assay, higher than 2.5 RLU/cm2 cutoff most often used. Neither method correlated well with FM results.

Conclusions

The methods for measuring environmental cleanliness have shown inconsistent correlation, but measure different parameters. Additional studies are needed to assess the correlation and predictive value of the three methods for room cleanliness assessment.

环境越来越被认为是医疗保健相关感染的一个因素。有几种测量环境污染的方法。我们的目的是比较定量微生物学和三磷酸腺苷(ATP)检测在医院表面样品清洁前后,并评估在同一房间的荧光标记结果。方法以10个房间为样本,对10个医院高接触环境表面进行清洁前后的相对光单位(RLU) ATP读数和菌落形成单位(CFU)定量测定。在同一房间进行清洁后评估荧光标记(FM)的去除。方法采用相关分析进行比较。结果与各自洁净度标准相比,ATP读数通常高于CFU读数。RLU和CFU方法的洁净度评价变化方向一致(通常在清洁后下降)。此外,CFU和RLU值与清洗前相关,而与清洗后无关。受试者工作特征(ROC)曲线显示,ATP测定的“干净”截止值为8 RLU/cm2,高于最常用的2.5 RLU/cm2截止值。两种方法都不能很好地与FM结果相关。结论环境洁净度测量方法相关性不一致,测量参数不同。需要进一步的研究来评估这三种方法在房间洁净度评估中的相关性和预测价值。
{"title":"A study of three methods for assessment of hospital environmental cleaning","authors":"Philip W. Smith MD ,&nbsp;Harlan Sayles MS ,&nbsp;Angela Hewlett MD, MS ,&nbsp;R. Jennifer Cavalieri BSN, RN ,&nbsp;Shawn G. Gibbs PhD ,&nbsp;Mark E. Rupp MD","doi":"10.1071/HI13001","DOIUrl":"10.1071/HI13001","url":null,"abstract":"<div><h3>Background</h3><p>The environment is increasingly appreciated as a factor in healthcare associated infections. Several methods for measuring environmental contamination are available. Our goal was to compare quantitative microbiology to adenosine triphosphate (ATP) detection on a sample of hospital surfaces both pre- and post-cleaning, and to assess fluorescent marker results in the same rooms.</p></div><div><h3>Methods</h3><p>In a sample of 10 rooms, ATP readings by relative light units (RLU) and quantitative determination of colony forming units (CFU) were measured pre- and post-cleaning on 10 high-touch hospital environmental surfaces. Removal of fluorescent markers (FM) was evaluated post-cleaning in the same rooms. Methods were compared using correlational analyses.</p></div><div><h3>Results</h3><p>The ATP readings were usually higher than CFU readings compared with their respective norms for cleanliness. The direction of change in cleanliness assessment (usually down after cleaning) was consistent between the RLU and CFU methods. In addition, CFU and RLU values correlated pre-cleaning, but not postcleaning. Areceiver operating characteristic (ROC) curve suggested a ‘clean’ cutoff of 8 RLU/cm<sup>2</sup> for the ATP assay, higher than 2.5 RLU/cm<sup>2</sup> cutoff most often used. Neither method correlated well with FM results.</p></div><div><h3>Conclusions</h3><p>The methods for measuring environmental cleanliness have shown inconsistent correlation, but measure different parameters. Additional studies are needed to assess the correlation and predictive value of the three methods for room cleanliness assessment.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 2","pages":"Pages 80-85"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI13001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59235547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection 联合使用质子泵抑制剂和抗生素是艰难梭菌感染的危险因素
Pub Date : 2013-06-01 DOI: 10.1071/HI12039
Daniel S. Kassavin MD , David Pham MD , Linda Pascarella RN, BSN, CIC , Kuo Yen-Hong ScM, MS , Michael A. Goldfarb MD, FACS

Purpose

A review of the incidence of Clostridium. difficile infection (CDI) at our hospital was performed due to the morbidity of CDI in its fulminate form, reports of the increased incidence of CDI in the United States and the increased use of medications associated with its onset.

Methods

The study was retrospective and took place over a 9-month period, from 1 January 2009 through 30 September 2009.

Results

There were 88 cases of CDI in the course of the review which amounted to 5.1 infections per 1000 patient hospital admissions. The percentage of overall admissions that were prescribed antibiotics and proton pump inhibitors (PPI), PPI alone or antibiotics alone were 17.1%, 15.5% and 24.3%, respectively. Of all cases of CDI, 59.1% of patients were on both a PPI and antibiotic, 9.1% were on a PPI alone and 13.6% were on an antibiotic alone. Patients on both proton pump inhibitors and antibiotics had an odds ratio of 8.30 (P < 0.0001) compared with patients on neither of these medications.

目的综述梭状芽孢杆菌的发病率。艰难梭菌感染(CDI)在我院进行治疗的原因是CDI以暴雷形式出现,有报道称CDI在美国的发病率增加,以及与CDI发病相关的药物使用增加。方法本研究为回顾性研究,研究时间为2009年1月1日至2009年9月30日,共9个月。结果本研究共发现88例CDI,每1000例住院患者感染5.1例。处方抗生素和质子泵抑制剂(PPI)、单独使用PPI或单独使用抗生素的总入院比例分别为17.1%、15.5%和24.3%。在所有CDI病例中,59.1%的患者同时使用PPI和抗生素,9.1%的患者单独使用PPI, 13.6%的患者单独使用抗生素。同时使用质子泵抑制剂和抗生素的患者的优势比为8.30 (P <0.0001),与不服用这两种药物的患者相比。
{"title":"The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection","authors":"Daniel S. Kassavin MD ,&nbsp;David Pham MD ,&nbsp;Linda Pascarella RN, BSN, CIC ,&nbsp;Kuo Yen-Hong ScM, MS ,&nbsp;Michael A. Goldfarb MD, FACS","doi":"10.1071/HI12039","DOIUrl":"10.1071/HI12039","url":null,"abstract":"<div><h3>Purpose</h3><p>A review of the incidence of <em>Clostridium. difficile</em> infection (CDI) at our hospital was performed due to the morbidity of CDI in its fulminate form, reports of the increased incidence of CDI in the United States and the increased use of medications associated with its onset.</p></div><div><h3>Methods</h3><p>The study was retrospective and took place over a 9-month period, from 1 January 2009 through 30 September 2009.</p></div><div><h3>Results</h3><p>There were 88 cases of CDI in the course of the review which amounted to 5.1 infections per 1000 patient hospital admissions. The percentage of overall admissions that were prescribed antibiotics and proton pump inhibitors (PPI), PPI alone or antibiotics alone were 17.1%, 15.5% and 24.3%, respectively. Of all cases of CDI, 59.1% of patients were on both a PPI and antibiotic, 9.1% were on a PPI alone and 13.6% were on an antibiotic alone. Patients on both proton pump inhibitors and antibiotics had an odds ratio of 8.30 (<em>P<!--> </em>&lt;<!--> <!-->0.0001) compared with patients on neither of these medications.</p></div>","PeriodicalId":90514,"journal":{"name":"Healthcare infection","volume":"18 2","pages":"Pages 76-79"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI12039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59234434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Healthcare infection
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1